Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Nektar Therapeutics logo

Nektar Therapeutics

Sector: Healthcare   

Industry: Biotechnology

0.93
 
USD
  
0.05
  
(5.55%)
Optionable: Yes  Market Cap: 165 M  90-day average vol: 1,610,594

Previous close: 0.8851  Open: 0.88  Bid: 0.9  Ask: 0.922
52 week range    
0.41   
   1.12
Peers   
PFE / 
MRK / 
AMGN / 
ENZN / 
BAX / 
JNJ / 
AZN / 
RELL / 
NVS / 
Last updated: Friday 29th March 2024
60
MarketXLS Rank
60
Value
76
Technical
44
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

NKTR Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in inventories500000.02 M237000.0383000.0-655000.0-1 M-3 M-509000.0-3 M699000.0
(Increase) Decrease in other current assets-3 M-825000.0-312000.0-5 M-32 M
(Increase) Decrease in other current liabilities-18 M-14 M-21 M-43 M-12 M-17 M-6 M-605000.0-1 M
(Increase) Decrease in other working capital1 M4 M-3 M7 M4 M
(Increase) Decrease in payables-6 M-412000.0518000.02 M971000.013 M2 M-12 M3 M-3 M
(Increase) Decrease in receivables-1 M-16 M4 M11 M-26 M6 M2 M12 M17 M5 M
Amortization of intangibles4 M7 M-2 M-15 M
AssetImpairmentCharge2 M66 M112 M
CapitalExpenditureReported10 M11 M6 M10 M14 M26 M7 M15 M6 M865000.0
Cash at beginning of period39 M12 M56 M60 M5 M195 M96 M199 M25 M88 M
Cash at end of period12 M56 M60 M5 M195 M96 M199 M25 M88 M35 M
Cash flow-142 M-73 M-117 M-80 M718 M-329 M-313 M-421 M-271 M-193 M
CashFlowFromContinuingInvestingActivities-38 M-14 M-82 M-29 M-1,380 M207 M496 M203 M366 M140 M
ChangeInAccountPayable-6 M-412000.0518000.02 M971000.013 M2 M-12 M3 M-3 M
ChangeInAccruedExpense273000.0-5 M191000.07 M28 M4 M9 M-24 M-20 M-17 M
ChangeInInterestPayable273000.0-3 M
ChangeInPayablesAndAccruedExpense-6 M-5 M709000.09 M29 M17 M11 M-35 M-17 M-20 M
ChangeInWorkingCapital-29 M-35 M-17 M-28 M-41 M7 M9 M-27 M3 M-11 M
ChangesInAccountReceivables-1 M-16 M4 M11 M-26 M6 M2 M12 M17 M5 M
Current deferred income taxes-102000.03 M-140000.0
Deferred income taxes-102000.03 M-140000.0
Depreciation13 M13 M15 M15 M11 M13 M14 M14 M13 M8 M
Depreciation unreconciled13 M13 M15 M15 M11 M13 M18 M21 M11 M-7 M
DepreciationAndAmortization13 M13 M15 M15 M11 M13 M18 M21 M11 M-7 M
Effect of exchange rate changes-109000.0-159000.0-124000.0-46000.0-101000.0-102000.020000.0-92000.0-327000.062000.0
FinancingCashFlow153 M131 M204 M54 M852 M23 M-80 M36 M2 M30000.0
Free cash flow-152 M-84 M-123 M-90 M707 M-355 M-321 M-428 M-296 M-192 M
GainLossOnSaleOfPPE-3 M1 M
IncomeTaxPaidSupplementalData964000.0860000.0757000.0556000.0618000.0555000.0539000.0325000.0272000.03 M
InterestPaidSupplementalData17 M20 M21 M20 M19 M19 M10 M
Issuance of capital stock117 M189 M790 M
IssuanceOfCapitalStock117 M189 M790 M
IssuanceOfDebt-4 M111 M-6 M-5 M-250 M8 M-33 M
Net cash from financing activities153 M131 M204 M54 M852 M23 M-80 M44 M-32 M30000.0
Net cash from investing activities-38 M-14 M-82 M-29 M-1,380 M207 M496 M203 M366 M140 M
Net cash from operating activities-142 M-73 M-117 M-80 M718 M-329 M-313 M-413 M-304 M-193 M
Net change in cash & cash equivalents-27 M43 M4 M-55 M190 M-99 M103 M-174 M63 M-53 M
Net income from continuing operations-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M-368 M-276 M
NetCommonStockIssuance117 M189 M790 M
NetForeignCurrencyExchangeGainLoss5 M
NetInvestmentPropertiesPurchaseAndSale-28 M-3 M-76 M-19 M-1,368 M233 M503 M218 M358 M139 M
NetInvestmentPurchaseAndSale-28 M-3 M-76 M-19 M-1,368 M233 M503 M218 M358 M139 M
NetIssuancePaymentsOfDebt-4 M111 M-6 M-5 M-250 M8 M-33 M
NetLongTermDebtIssuance-4 M111 M-6 M-5 M-250 M8 M-33 M
NetPPEPurchaseAndSale-10 M-11 M-6 M-10 M-12 M-26 M-7 M-15 M8 M380000.0
Operating (gains) losses-9 M249000.012 M-10 M2 M2 M5 M1 M-3 M6 M
Other financing charges net-7 M146 M3 M750000.0
Other investing changes net25 M
Other non-cash items-64 M30 M25 M39 M65 M90 M99 M108 M84 M95 M
PensionAndEmployeeBenefitExpense-9 M249000.012 M-10 M2 M2 M5 M1 M-6 M
ProceedsFromStockOptionExercised47 M32 M20 M60 M62 M23 M23 M33 M758000.030000.0
Purchase of Float term investments-297 M-298 M-335 M-404 M-2,271 M-1,381 M-988 M-961 M-468 M-512 M
Purchase of property plant & equipment-10 M-11 M-6 M-10 M-12 M-26 M-7 M-15 M8 M380000.0
Purchase of short term investments241 M
PurchaseOfInvestment-297 M-298 M-335 M-404 M-2,271 M-1,381 M-988 M-961 M-468 M-512 M
PurchaseOfPPE-10 M-11 M-6 M-10 M-14 M-26 M-7 M-15 M-6 M-865000.0
Repayment of debt-4 M-130 M-6 M-5 M-250 M8 M-33 M
RepaymentOfDebt-4 M-130 M-6 M-5 M-250 M8 M-33 M
Revenue per share4 M7 M-2 M-15 M
Sale of short term investments270 M269 M259 M385 M903 M1,614 M1,491 M1,178 M826 M651 M
SaleOfInvestment270 M269 M259 M385 M903 M1,614 M1,491 M1,178 M826 M651 M
SaleOfPPE3 M13 M1 M
StockBasedCompensation17 M20 M26 M37 M88 M100 M94 M95 M57 M33 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University